VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SGMT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SGMTSagimet Biosciences Inc.
$9.85$321M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSGMTQuarterly Balance Sheet

Sagimet Biosciences Inc. (SGMT) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Sagimet Biosciences Inc. (SGMT) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

SGMT Balance Sheet

Quarterly statement

SGMT Balance Sheet

Sagimet Biosciences Inc. (SGMT) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22
Total Current Assets243.99M107.72M116.4M119.23M127.2M146.07M152.77M157.19M166.75M194.49M96.65M102.82M21.35M27.05M32.79M
Cash & Short-Term Investments240.13M104.54M113.12M116.69M125.41M144.57M151.25M152.49M166.37M193.71M94.9M101.84M18.51M25.25M32.34M
Cash Only165.9M36.63M35.02M32.5M42.33M64.72M75.84M77.01M95.96M176.78M75.14M101.84M18.51M12.34M158K
Short-Term Investments74.23M67.91M78.1M84.2M83.08M79.85M75.41M75.47M70.41M16.93M19.76M0012.92M32.19M
Accounts Receivable000000000000000
Days Sales Outstanding---------------
Inventory000000000000000
Days Inventory Outstanding---------------
Other Current Assets0650K481K253K793K888K463K407K130K108K397K77K2.74M1.42M34K
Total Non-Current Assets19.44M39K78K9.17M10.21M100K7.49M17.59M22.27M37K73K109K144K205K239K
Property, Plant & Equipment1.95M39K78K115K152K38K77K114K151K37K73K109K144K178K212K
Fixed Asset Turnover-----------15.81x---
Goodwill000000000000000
Intangible Assets000000000000000
Long-Term Investments0008.81M10.06M07.41M17.47M22.12M000000
Other Non-Current Assets17.49M00247K062K000000027K27K
Total Assets263.43M107.75M116.48M128.4M137.41M146.17M160.26M174.78M189.02M194.53M96.72M102.92M21.5M27.25M33.03M
Asset Turnover-----------0.03x---
Asset Growth %91.72%-26.28%-27.32%-26.53%-27.31%-24.86%65.7%69.81%779.24%613.79%192.81%----
Total Current Liabilities5.42M5.3M5.1M9.15M7.25M7.18M4.45M4.09M5.73M4.51M5.65M5.05M5.29M5.29M5.28M
Accounts Payable1.13M2.3M1.31M4.24M1.92M3.22M1.43M1.15M1.99M531K186K1.7M2.72M1.46M1.13M
Days Payables Outstanding---------------
Short-Term Debt000115K0000026K00000
Deferred Revenue (Current)000000000000000
Other Current Liabilities015K27K3.5M1K16K5K11K10K3.64M556K95K103K1.03M57K
Current Ratio45.02x20.34x22.82x13.04x17.55x20.34x34.30x38.41x29.11x43.12x17.09x20.36x4.04x5.12x6.21x
Quick Ratio45.02x20.34x22.82x13.04x17.55x20.34x34.30x38.41x29.11x43.12x17.09x20.36x4.04x5.12x6.21x
Cash Conversion Cycle---------------
Total Non-Current Liabilities1.86M00000000001K214.63M39K214.7M
Long-Term Debt000000000000000
Capital Lease Obligations1.86M00000000000039K78K
Deferred Tax Liabilities000000000000000
Other Non-Current Liabilities000000000001K214.63M0214.62M
Total Liabilities7.28M5.3M5.1M9.15M7.25M7.18M4.45M4.09M5.73M4.51M5.65M5.05M219.91M5.33M219.98M
Total Debt1.94M39K78K115K152K39K78K116K153K26K65K103K140K176K211K
Net Debt-163.96M-36.59M-34.94M-32.38M-42.17M-64.68M-75.76M-76.9M-95.81M-176.75M-75.07M-101.74M-18.37M-12.16M53K
Debt / Equity0.01x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.01x-
Debt / EBITDA---------------
Net Debt / EBITDA---------------
Interest Coverage---------------
Total Equity256.15M102.46M111.38M119.25M130.16M138.99M155.81M170.68M183.29M190.02M91.06M97.88M-198.41M21.93M-186.95M
Equity Growth %96.8%-26.28%-28.51%-30.13%-28.99%-26.85%71.09%74.39%192.38%766.59%148.71%----
Book Value per Share4.823.153.423.674.044.324.845.315.746.545.015.38-8.950.99-8.43
Total Shareholders' Equity256.15M102.46M111.38M119.25M130.16M138.99M155.81M170.68M183.29M190.02M91.06M97.88M-198.41M21.93M-186.95M
Common Stock6K3K3K3K3K3K3K3K3K3K2K2K1K1K1K
Retained Earnings-370.95M-357M-346.35M-336.78M-323.87M-313.49M-295.31M-279.11M-264.49M-256.37M-249.74M-241.59M-235.24M-228.46M-221.87M
Treasury Stock000000000000000
Accumulated OCI-77K8K120K117K76K121K230K441K-23K7K30K00-13K-84K
Minority Interest000000000000000